Ann: Annual General Meeting Presentation, page-65

First 65 Last

Share
Profile

Follow
MrLearner

800 Posts.

235

08/12/23

13:02

Post #: 71347317
Share

Originally posted by mephistophles: ↑

Interesting. I have a completely different take.

On adding "absolutely no value", I disagree. I think it's a solid strategic move to align the company's identity with its evolving vision and goals. In my opinion, Antisense Therapeutics is a terrible company name that we've all become comfortable with. I'd wager that if you A/B tested the two names with people that have never heard of us (basically everyone), Percheron Therapeutics would absolutely crush Antisense Therapeutics in every area, especially trustability.

On the search term "antisense", this should tell you how important it is:

https://trends.google.com/trends/explore?date=today%205-y&q=Antisense&hl=en-GB(not at all).

Further to that:
- it's only the top result under certain conditions (searching from Australia and/or whilst logged into an Australian Google account)
- we'd likely hold onto the domain name

On the topic of Facebook/Twitter, we're a completely unknown, small cap biotech stock. There is no brand reputation/recognition being jettisoned here. On the contrary, congnitive bias is real and the word "anti" has negative connotations.

Cheers and good luck!

Expand

I agree with you Meph that Antisense is a very silly name for all the reasons you mention in your post. I mentioned my displeasure with the name years ago in a post and very glad to see a change. Cant say for sure that Percheron Therapeutics is a name I would have chosen but I can't suggest what would have been better.

ANP Price at posting: 5.3¢ Sentiment: Buy Disclosure: Held
6 Upvote

2 Great analysis

Reply

Top Stories

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

What's causing the cost-of-living crisis, and how to navigate it

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins